Take our poll: Caregivers, what do you find most difficult about caregiving?
Weigh in: What are the best and worst gifts for people with breast cancer?

HER2-Positive Brain Mets Respond to Enhertu

moderators
moderators Posts: 8,633
in Stage IV/Metastatic Breast Cancer ONLY

HER2-Positive Brain Mets Respond to Enhertu

September 12, 2014

The targeted therapy Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) helped control areas of metastatic HER2-positive breast cancer in the brain, according to results from the DESTINY-Breast12 study presented on Sept. 13 at ESMO 2024. Read more…

Tagged:

Categories

Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.